Therapie des nicht kleinzelligen Lungenkarzinoms (NSCLC) im lokal fortgeschrittenen Stadium (inoperables IIIA/IIIB)

Publisher： Karger

E-ISSN： 2296-5262|29|2|11-14

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.29, Iss.2, 2006-09, pp. : 11-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Therapie des nicht kleinzelligen Lungenkarzinoms (NSCLC) im Stadium IV

By  

Oncology Research and Treatment, Vol. 29, Iss. 2, 2006-09 ,pp. : 15-19

Karger

Access to resources Recommend Favorite

Operation und adjuvante Therapie des nicht kleinzelligen Lungenkarzinoms (NSCLC) (Stadium I bis operables IIIA)

By  

Oncology Research and Treatment, Vol. 29, Iss. 2, 2006-09 ,pp. : 7-10

Karger

Access to resources Recommend Favorite

Gemcitabin in der First-line-Therapie des lokal fortgeschrittenen und metastasierten nicht-kleinzelligen Bronchialkarzinoms (NSCLC): Ergebnisübersicht randomisierter Phase-III-Studien

By  

Oncology Research and Treatment, Vol. 28, Iss. 1, 2005-03 ,pp. : 1-28

Karger

Access to resources Recommend Favorite

Diagnostik des nicht kleinzelligen Lungenkarzinoms (NSCLC)

By  

Oncology Research and Treatment, Vol. 29, Iss. 2, 2006-09 ,pp. : 3-6

Karger

Access to resources Recommend Favorite

Docetaxel (Taxotere®) in der First-line-Therapie des fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms (NSCLC)

By  

Oncology Research and Treatment, Vol. 26, Iss. 7, 2004-11 ,pp. : 26-32

Karger

Access to resources Recommend Favorite